Class Review Schedule

The next D&T Committee meeting will be held March 7, 2018

HFS will be reviewing the following classes for the March meeting:

  • Multiple Sclerosis-Oral

  • Multiple Sclerosis-Injectable

  • Growth Hormone

  • Inhaled Aminoglycosides (tobramycin)

All clinical and financial submissions for this meeting must be sent to the Department no later than 3pm CST on February 21, 2018.  Any changes to drug status will become effective on or after April 1, 2018







 Need Assistance?